Global Companion Diagnostic Tests Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 103380
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Companion Diagnostic Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Companion Diagnostic Tests market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pharmaceutical and Biotechnology Companies accounting for % of the Companion Diagnostic Tests global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Protein Detection segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Companion Diagnostic Tests include F. Hoffman LA Roche Ltd., QIAGEN, Illumina, Inc., Abbott, Agilent Technologies, Inc., and Genomic Health, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Companion Diagnostic Tests market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Protein Detection

DNA Detection

Hybridization

Biomarker

Others

Market segment by Application, can be divided into

Pharmaceutical and Biotechnology Companies

Medical Device Companies

Research Institutes

Market segment by players, this report covers

F. Hoffman LA Roche Ltd.

QIAGEN, Illumina, Inc.

Abbott

Agilent Technologies, Inc.

Genomic Health, Inc.

BioMerieux SA, BioGenex

AGENDIA NV

Siemens Healthcare GmBH

Thermo Fisher Scientific, Inc.

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Companion Diagnostic Tests product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Companion Diagnostic Tests, with revenue, gross margin and global market share of Companion Diagnostic Tests from 2019 to 2022.

Chapter 3, the Companion Diagnostic Tests competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Companion Diagnostic Tests market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Companion Diagnostic Tests research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Companion Diagnostic Tests

1.2 Classification of Companion Diagnostic Tests by Type

1.2.1 Overview: Global Companion Diagnostic Tests Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Companion Diagnostic Tests Revenue Market Share by Type in 2021

1.2.3 Protein Detection

1.2.4 DNA Detection

1.2.5 Hybridization

1.2.6 Biomarker

1.2.7 Others

1.3 Global Companion Diagnostic Tests Market by Application

1.3.1 Overview: Global Companion Diagnostic Tests Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Pharmaceutical and Biotechnology Companies

1.3.3 Medical Device Companies

1.3.4 Research Institutes

1.4 Global Companion Diagnostic Tests Market Size & Forecast

1.5 Global Companion Diagnostic Tests Market Size and Forecast by Region

1.5.1 Global Companion Diagnostic Tests Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Companion Diagnostic Tests Market Size by Region, (2017-2022)

1.5.3 North America Companion Diagnostic Tests Market Size and Prospect (2017-2028)

1.5.4 Europe Companion Diagnostic Tests Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Companion Diagnostic Tests Market Size and Prospect (2017-2028)

1.5.6 South America Companion Diagnostic Tests Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Companion Diagnostic Tests Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Companion Diagnostic Tests Market Drivers

1.6.2 Companion Diagnostic Tests Market Restraints

1.6.3 Companion Diagnostic Tests Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 F. Hoffman LA Roche Ltd.

2.1.1 F. Hoffman LA Roche Ltd. Details

2.1.2 F. Hoffman LA Roche Ltd. Major Business

2.1.3 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Product and Solutions

2.1.4 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 F. Hoffman LA Roche Ltd. Recent Developments and Future Plans

2.2 QIAGEN, Illumina, Inc.

2.2.1 QIAGEN, Illumina, Inc. Details

2.2.2 QIAGEN, Illumina, Inc. Major Business

2.2.3 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Product and Solutions

2.2.4 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 QIAGEN, Illumina, Inc. Recent Developments and Future Plans

2.3 Abbott

2.3.1 Abbott Details

2.3.2 Abbott Major Business

2.3.3 Abbott Companion Diagnostic Tests Product and Solutions

2.3.4 Abbott Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Abbott Recent Developments and Future Plans

2.4 Agilent Technologies, Inc.

2.4.1 Agilent Technologies, Inc. Details

2.4.2 Agilent Technologies, Inc. Major Business

2.4.3 Agilent Technologies, Inc. Companion Diagnostic Tests Product and Solutions

2.4.4 Agilent Technologies, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Agilent Technologies, Inc. Recent Developments and Future Plans

2.5 Genomic Health, Inc.

2.5.1 Genomic Health, Inc. Details

2.5.2 Genomic Health, Inc. Major Business

2.5.3 Genomic Health, Inc. Companion Diagnostic Tests Product and Solutions

2.5.4 Genomic Health, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Genomic Health, Inc. Recent Developments and Future Plans

2.6 BioMerieux SA, BioGenex

2.6.1 BioMerieux SA, BioGenex Details

2.6.2 BioMerieux SA, BioGenex Major Business

2.6.3 BioMerieux SA, BioGenex Companion Diagnostic Tests Product and Solutions

2.6.4 BioMerieux SA, BioGenex Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 BioMerieux SA, BioGenex Recent Developments and Future Plans

2.7 AGENDIA NV

2.7.1 AGENDIA NV Details

2.7.2 AGENDIA NV Major Business

2.7.3 AGENDIA NV Companion Diagnostic Tests Product and Solutions

2.7.4 AGENDIA NV Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 AGENDIA NV Recent Developments and Future Plans

2.8 Siemens Healthcare GmBH

2.8.1 Siemens Healthcare GmBH Details

2.8.2 Siemens Healthcare GmBH Major Business

2.8.3 Siemens Healthcare GmBH Companion Diagnostic Tests Product and Solutions

2.8.4 Siemens Healthcare GmBH Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Siemens Healthcare GmBH Recent Developments and Future Plans

2.9 Thermo Fisher Scientific, Inc.

2.9.1 Thermo Fisher Scientific, Inc. Details

2.9.2 Thermo Fisher Scientific, Inc. Major Business

2.9.3 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Product and Solutions

2.9.4 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Companion Diagnostic Tests Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Companion Diagnostic Tests Players Market Share in 2021

3.2.2 Top 10 Companion Diagnostic Tests Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Companion Diagnostic Tests Players Head Office, Products and Services Provided

3.4 Companion Diagnostic Tests Mergers & Acquisitions

3.5 Companion Diagnostic Tests New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Companion Diagnostic Tests Revenue and Market Share by Type (2017-2022)

4.2 Global Companion Diagnostic Tests Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Companion Diagnostic Tests Revenue Market Share by Application (2017-2022)

5.2 Global Companion Diagnostic Tests Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Companion Diagnostic Tests Revenue by Type (2017-2028)

6.2 North America Companion Diagnostic Tests Revenue by Application (2017-2028)

6.3 North America Companion Diagnostic Tests Market Size by Country

6.3.1 North America Companion Diagnostic Tests Revenue by Country (2017-2028)

6.3.2 United States Companion Diagnostic Tests Market Size and Forecast (2017-2028)

6.3.3 Canada Companion Diagnostic Tests Market Size and Forecast (2017-2028)

6.3.4 Mexico Companion Diagnostic Tests Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Companion Diagnostic Tests Revenue by Type (2017-2028)

7.2 Europe Companion Diagnostic Tests Revenue by Application (2017-2028)

7.3 Europe Companion Diagnostic Tests Market Size by Country

7.3.1 Europe Companion Diagnostic Tests Revenue by Country (2017-2028)

7.3.2 Germany Companion Diagnostic Tests Market Size and Forecast (2017-2028)

7.3.3 France Companion Diagnostic Tests Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Companion Diagnostic Tests Market Size and Forecast (2017-2028)

7.3.5 Russia Companion Diagnostic Tests Market Size and Forecast (2017-2028)

7.3.6 Italy Companion Diagnostic Tests Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Companion Diagnostic Tests Revenue by Type (2017-2028)

8.2 Asia-Pacific Companion Diagnostic Tests Revenue by Application (2017-2028)

8.3 Asia-Pacific Companion Diagnostic Tests Market Size by Region

8.3.1 Asia-Pacific Companion Diagnostic Tests Revenue by Region (2017-2028)

8.3.2 China Companion Diagnostic Tests Market Size and Forecast (2017-2028)

8.3.3 Japan Companion Diagnostic Tests Market Size and Forecast (2017-2028)

8.3.4 South Korea Companion Diagnostic Tests Market Size and Forecast (2017-2028)

8.3.5 India Companion Diagnostic Tests Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Companion Diagnostic Tests Market Size and Forecast (2017-2028)

8.3.7 Australia Companion Diagnostic Tests Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Companion Diagnostic Tests Revenue by Type (2017-2028)

9.2 South America Companion Diagnostic Tests Revenue by Application (2017-2028)

9.3 South America Companion Diagnostic Tests Market Size by Country

9.3.1 South America Companion Diagnostic Tests Revenue by Country (2017-2028)

9.3.2 Brazil Companion Diagnostic Tests Market Size and Forecast (2017-2028)

9.3.3 Argentina Companion Diagnostic Tests Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Companion Diagnostic Tests Revenue by Type (2017-2028)

10.2 Middle East & Africa Companion Diagnostic Tests Revenue by Application (2017-2028)

10.3 Middle East & Africa Companion Diagnostic Tests Market Size by Country

10.3.1 Middle East & Africa Companion Diagnostic Tests Revenue by Country (2017-2028)

10.3.2 Turkey Companion Diagnostic Tests Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Companion Diagnostic Tests Market Size and Forecast (2017-2028)

10.3.4 UAE Companion Diagnostic Tests Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Companion Diagnostic Tests Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Companion Diagnostic Tests Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Companion Diagnostic Tests Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Companion Diagnostic Tests Revenue (USD Million) by Region (2017-2022)

Table 5. Global Companion Diagnostic Tests Revenue Market Share by Region (2023-2028)

Table 6. F. Hoffman LA Roche Ltd. Corporate Information, Head Office, and Major Competitors

Table 7. F. Hoffman LA Roche Ltd. Major Business

Table 8. F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Product and Solutions

Table 9. F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. QIAGEN, Illumina, Inc. Corporate Information, Head Office, and Major Competitors

Table 11. QIAGEN, Illumina, Inc. Major Business

Table 12. QIAGEN, Illumina, Inc. Companion Diagnostic Tests Product and Solutions

Table 13. QIAGEN, Illumina, Inc. Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Abbott Corporate Information, Head Office, and Major Competitors

Table 15. Abbott Major Business

Table 16. Abbott Companion Diagnostic Tests Product and Solutions

Table 17. Abbott Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Agilent Technologies, Inc. Corporate Information, Head Office, and Major Competitors

Table 19. Agilent Technologies, Inc. Major Business

Table 20. Agilent Technologies, Inc. Companion Diagnostic Tests Product and Solutions

Table 21. Agilent Technologies, Inc. Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Genomic Health, Inc. Corporate Information, Head Office, and Major Competitors

Table 23. Genomic Health, Inc. Major Business

Table 24. Genomic Health, Inc. Companion Diagnostic Tests Product and Solutions

Table 25. Genomic Health, Inc. Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. BioMerieux SA, BioGenex Corporate Information, Head Office, and Major Competitors

Table 27. BioMerieux SA, BioGenex Major Business

Table 28. BioMerieux SA, BioGenex Companion Diagnostic Tests Product and Solutions

Table 29. BioMerieux SA, BioGenex Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. AGENDIA NV Corporate Information, Head Office, and Major Competitors

Table 31. AGENDIA NV Major Business

Table 32. AGENDIA NV Companion Diagnostic Tests Product and Solutions

Table 33. AGENDIA NV Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Siemens Healthcare GmBH Corporate Information, Head Office, and Major Competitors

Table 35. Siemens Healthcare GmBH Major Business

Table 36. Siemens Healthcare GmBH Companion Diagnostic Tests Product and Solutions

Table 37. Siemens Healthcare GmBH Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Thermo Fisher Scientific, Inc. Corporate Information, Head Office, and Major Competitors

Table 39. Thermo Fisher Scientific, Inc. Major Business

Table 40. Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Product and Solutions

Table 41. Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Global Companion Diagnostic Tests Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 43. Global Companion Diagnostic Tests Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 44. Breakdown of Companion Diagnostic Tests by Company Type (Tier 1, Tier 2 and Tier 3)

Table 45. Companion Diagnostic Tests Players Head Office, Products and Services Provided

Table 46. Companion Diagnostic Tests Mergers & Acquisitions in the Past Five Years

Table 47. Companion Diagnostic Tests New Entrants and Expansion Plans

Table 48. Global Companion Diagnostic Tests Revenue (USD Million) by Type (2017-2022)

Table 49. Global Companion Diagnostic Tests Revenue Share by Type (2017-2022)

Table 50. Global Companion Diagnostic Tests Revenue Forecast by Type (2023-2028)

Table 51. Global Companion Diagnostic Tests Revenue by Application (2017-2022)

Table 52. Global Companion Diagnostic Tests Revenue Forecast by Application (2023-2028)

Table 53. North America Companion Diagnostic Tests Revenue by Type (2017-2022) & (USD Million)

Table 54. North America Companion Diagnostic Tests Revenue by Type (2023-2028) & (USD Million)

Table 55. North America Companion Diagnostic Tests Revenue by Application (2017-2022) & (USD Million)

Table 56. North America Companion Diagnostic Tests Revenue by Application (2023-2028) & (USD Million)

Table 57. North America Companion Diagnostic Tests Revenue by Country (2017-2022) & (USD Million)

Table 58. North America Companion Diagnostic Tests Revenue by Country (2023-2028) & (USD Million)

Table 59. Europe Companion Diagnostic Tests Revenue by Type (2017-2022) & (USD Million)

Table 60. Europe Companion Diagnostic Tests Revenue by Type (2023-2028) & (USD Million)

Table 61. Europe Companion Diagnostic Tests Revenue by Application (2017-2022) & (USD Million)

Table 62. Europe Companion Diagnostic Tests Revenue by Application (2023-2028) & (USD Million)

Table 63. Europe Companion Diagnostic Tests Revenue by Country (2017-2022) & (USD Million)

Table 64. Europe Companion Diagnostic Tests Revenue by Country (2023-2028) & (USD Million)

Table 65. Asia-Pacific Companion Diagnostic Tests Revenue by Type (2017-2022) & (USD Million)

Table 66. Asia-Pacific Companion Diagnostic Tests Revenue by Type (2023-2028) & (USD Million)

Table 67. Asia-Pacific Companion Diagnostic Tests Revenue by Application (2017-2022) & (USD Million)

Table 68. Asia-Pacific Companion Diagnostic Tests Revenue by Application (2023-2028) & (USD Million)

Table 69. Asia-Pacific Companion Diagnostic Tests Revenue by Region (2017-2022) & (USD Million)

Table 70. Asia-Pacific Companion Diagnostic Tests Revenue by Region (2023-2028) & (USD Million)

Table 71. South America Companion Diagnostic Tests Revenue by Type (2017-2022) & (USD Million)

Table 72. South America Companion Diagnostic Tests Revenue by Type (2023-2028) & (USD Million)

Table 73. South America Companion Diagnostic Tests Revenue by Application (2017-2022) & (USD Million)

Table 74. South America Companion Diagnostic Tests Revenue by Application (2023-2028) & (USD Million)

Table 75. South America Companion Diagnostic Tests Revenue by Country (2017-2022) & (USD Million)

Table 76. South America Companion Diagnostic Tests Revenue by Country (2023-2028) & (USD Million)

Table 77. Middle East & Africa Companion Diagnostic Tests Revenue by Type (2017-2022) & (USD Million)

Table 78. Middle East & Africa Companion Diagnostic Tests Revenue by Type (2023-2028) & (USD Million)

Table 79. Middle East & Africa Companion Diagnostic Tests Revenue by Application (2017-2022) & (USD Million)

Table 80. Middle East & Africa Companion Diagnostic Tests Revenue by Application (2023-2028) & (USD Million)

Table 81. Middle East & Africa Companion Diagnostic Tests Revenue by Country (2017-2022) & (USD Million)

Table 82. Middle East & Africa Companion Diagnostic Tests Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Companion Diagnostic Tests Picture

Figure 2. Global Companion Diagnostic Tests Revenue Market Share by Type in 2021

Figure 3. Protein Detection

Figure 4. DNA Detection

Figure 5. Hybridization

Figure 6. Biomarker

Figure 7. Others

Figure 8. Companion Diagnostic Tests Revenue Market Share by Application in 2021

Figure 9. Pharmaceutical and Biotechnology Companies Picture

Figure 10. Medical Device Companies Picture

Figure 11. Research Institutes Picture

Figure 12. Global Companion Diagnostic Tests Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Companion Diagnostic Tests Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Companion Diagnostic Tests Revenue Market Share by Region (2017-2028)

Figure 15. Global Companion Diagnostic Tests Revenue Market Share by Region in 2021

Figure 16. North America Companion Diagnostic Tests Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Companion Diagnostic Tests Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Companion Diagnostic Tests Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Companion Diagnostic Tests Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Companion Diagnostic Tests Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Companion Diagnostic Tests Market Drivers

Figure 22. Companion Diagnostic Tests Market Restraints

Figure 23. Companion Diagnostic Tests Market Trends

Figure 24. F. Hoffman LA Roche Ltd. Recent Developments and Future Plans

Figure 25. QIAGEN, Illumina, Inc. Recent Developments and Future Plans

Figure 26. Abbott Recent Developments and Future Plans

Figure 27. Agilent Technologies, Inc. Recent Developments and Future Plans

Figure 28. Genomic Health, Inc. Recent Developments and Future Plans

Figure 29. BioMerieux SA, BioGenex Recent Developments and Future Plans

Figure 30. AGENDIA NV Recent Developments and Future Plans

Figure 31. Siemens Healthcare GmBH Recent Developments and Future Plans

Figure 32. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans

Figure 33. Global Companion Diagnostic Tests Revenue Share by Players in 2021

Figure 34. Companion Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 35. Global Top 3 Players Companion Diagnostic Tests Revenue Market Share in 2021

Figure 36. Global Top 10 Players Companion Diagnostic Tests Revenue Market Share in 2021

Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 38. Global Companion Diagnostic Tests Revenue Share by Type in 2021

Figure 39. Global Companion Diagnostic Tests Market Share Forecast by Type (2023-2028)

Figure 40. Global Companion Diagnostic Tests Revenue Share by Application in 2021

Figure 41. Global Companion Diagnostic Tests Market Share Forecast by Application (2023-2028)

Figure 42. North America Companion Diagnostic Tests Sales Market Share by Type (2017-2028)

Figure 43. North America Companion Diagnostic Tests Sales Market Share by Application (2017-2028)

Figure 44. North America Companion Diagnostic Tests Revenue Market Share by Country (2017-2028)

Figure 45. United States Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Canada Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Mexico Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Europe Companion Diagnostic Tests Sales Market Share by Type (2017-2028)

Figure 49. Europe Companion Diagnostic Tests Sales Market Share by Application (2017-2028)

Figure 50. Europe Companion Diagnostic Tests Revenue Market Share by Country (2017-2028)

Figure 51. Germany Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. France Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. United Kingdom Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Russia Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Italy Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Asia-Pacific Companion Diagnostic Tests Sales Market Share by Type (2017-2028)

Figure 57. Asia-Pacific Companion Diagnostic Tests Sales Market Share by Application (2017-2028)

Figure 58. Asia-Pacific Companion Diagnostic Tests Revenue Market Share by Region (2017-2028)

Figure 59. China Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Japan Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. South Korea Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. India Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Southeast Asia Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Australia Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. South America Companion Diagnostic Tests Sales Market Share by Type (2017-2028)

Figure 66. South America Companion Diagnostic Tests Sales Market Share by Application (2017-2028)

Figure 67. South America Companion Diagnostic Tests Revenue Market Share by Country (2017-2028)

Figure 68. Brazil Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Argentina Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Middle East and Africa Companion Diagnostic Tests Sales Market Share by Type (2017-2028)

Figure 71. Middle East and Africa Companion Diagnostic Tests Sales Market Share by Application (2017-2028)

Figure 72. Middle East and Africa Companion Diagnostic Tests Revenue Market Share by Country (2017-2028)

Figure 73. Turkey Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Saudi Arabia Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. UAE Companion Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Methodology

Figure 77. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz